Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
46
IRDM Quote, Financials, Valuation and Earnings
Last price:
$19.04
Seasonality move
:
0.74%
Day range:
$18.07 - $19.16
52-week range:
$15.65 - $34.45
Dividend yield:
3.05%
P/E ratio:
16.66x
P/S ratio:
2.40x
P/B ratio:
4.43x
Volume:
2.1M
Avg. volume:
2.6M
1-year change:
-30.89%
Market cap:
$2B
Revenue:
$830.7M
EPS (TTM):
$1.14
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $583.4M | $614.5M | $721M | $790.7M | $830.7M | |
| Revenue Growth (YoY) | 4.1% | 5.32% | 17.34% | 9.67% | 5.05% | |
| Cost of Revenues | $445.9M | $455.8M | $504.6M | $507.6M | $433.7M | |
| Gross Profit | $137.6M | $158.7M | $216.4M | $283.1M | $397M | |
| Gross Profit Margin | 23.58% | 25.82% | 30.01% | 35.8% | 47.79% | |
| R&D Expenses | $12M | $11.9M | $16.2M | $20.3M | $28.4M | |
| Selling, General & Admin | $90.1M | $100.5M | $123.5M | $143.7M | $168.2M | |
| Other Inc / (Exp) | -$30.2M | -$1.3M | -$1.1M | $4M | $534K | |
| Operating Expenses | $102.1M | $112.4M | $139.7M | $164M | $193.5M | |
| Operating Income | $35.5M | $46.3M | $76.7M | $119.1M | $203.5M | |
| Net Interest Expenses | $98.6M | $73.9M | $72.1M | $102.3M | $102.8M | |
| EBT. Incl. Unusual Items | -$89M | -$28.9M | $10.5M | -$4.7M | $109.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$32.9M | -$19.6M | $292K | -$26.3M | $12.3M | |
| Net Income to Company | -$56.1M | -$9.3M | $17.4M | $30.8M | $225.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$56.1M | -$9.3M | $8.7M | $15.4M | $112.8M | |
| Basic EPS (Cont. Ops) | -$0.42 | -$0.07 | $0.07 | $0.12 | $0.95 | |
| Diluted EPS (Cont. Ops) | -$0.42 | -$0.07 | $0.07 | $0.12 | $0.94 | |
| Weighted Average Basic Share | $133.5M | $133.5M | $128.3M | $125.6M | $118.6M | |
| Weighted Average Diluted Share | $133.5M | $133.5M | $130.1M | $127.2M | $119.8M | |
| EBITDA | $338.7M | $351.7M | $380.2M | $401.6M | $406.6M | |
| EBIT | $35.5M | $46.3M | $76.7M | $119.1M | $203.5M | |
| Revenue (Reported) | $583.4M | $614.5M | $721M | $790.7M | $830.7M | |
| Operating Income (Reported) | $35.5M | $46.3M | $76.7M | $119.1M | $203.5M | |
| Operating Income (Adjusted) | $35.5M | $46.3M | $76.7M | $119.1M | $203.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $162.2M | $184.1M | $197.6M | $212.8M | $226.9M | |
| Revenue Growth (YoY) | 7.06% | 13.51% | 7.36% | 7.68% | 6.66% | |
| Cost of Revenues | $118.4M | $129.2M | $131M | $107.8M | $116.4M | |
| Gross Profit | $43.7M | $54.9M | $66.6M | $105M | $110.5M | |
| Gross Profit Margin | 26.97% | 29.82% | 33.68% | 49.35% | 48.71% | |
| R&D Expenses | $2.8M | $4.9M | $5M | $6.2M | $4.9M | |
| Selling, General & Admin | -- | -- | -- | $44M | $35.5M | |
| Other Inc / (Exp) | -$960K | -$146K | $343K | $312K | -- | |
| Operating Expenses | $28.7M | $37M | $38.4M | $49.7M | $40.5M | |
| Operating Income | $15M | $17.9M | $28.2M | $55.3M | $70.1M | |
| Net Interest Expenses | $18.5M | $19.8M | $37.3M | $27.8M | $25M | |
| EBT. Incl. Unusual Items | -$3.5M | $96K | -$6.2M | $30.9M | $47.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.5M | -$2.1M | -$6M | $6M | $10M | |
| Net Income to Company | -$735K | $4.3M | -$24.3M | $48.9M | -$67.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.1M | $2.1M | -$1.6M | $24.4M | $37.1M | |
| Basic EPS (Cont. Ops) | -$0.02 | $0.02 | -$0.01 | $0.21 | $0.35 | |
| Diluted EPS (Cont. Ops) | -$0.02 | $0.02 | -$0.01 | $0.21 | $0.35 | |
| Weighted Average Basic Share | $132.9M | $127.7M | $125.2M | $117.4M | $106.1M | |
| Weighted Average Diluted Share | $132.9M | $129.1M | $125.2M | $118.1M | $106.5M | |
| EBITDA | $92.7M | $94.3M | $105M | $106.4M | $123.1M | |
| EBIT | $15M | $17.9M | $28.2M | $55.3M | $70.1M | |
| Revenue (Reported) | $162.2M | $184.1M | $197.6M | $212.8M | $226.9M | |
| Operating Income (Reported) | $15M | $17.9M | $28.2M | $55.3M | $70.1M | |
| Operating Income (Adjusted) | $15M | $17.9M | $28.2M | $55.3M | $70.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $605.1M | $683.1M | $789.8M | $812.4M | $871.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $452.1M | $485.5M | $531.9M | $430.4M | $459.1M | |
| Gross Profit | $153M | $197.6M | $257.9M | $382M | $412.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.3M | $14.2M | $20.3M | $25.6M | $23.2M | |
| Selling, General & Admin | -- | -- | -- | $44M | $156.6M | |
| Other Inc / (Exp) | -$1.4M | -$566K | $275K | $2.7M | -- | |
| Operating Expenses | $112.3M | $129.1M | $166.3M | $187M | $179.4M | |
| Operating Income | $40.7M | $68.6M | $91.6M | $195M | $233.1M | |
| Net Interest Expenses | $84.7M | $67M | $101.6M | $98.8M | $99.6M | |
| EBT. Incl. Unusual Items | -$41.4M | $5.1M | -$36.5M | $109.5M | $141.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$30M | $1.5M | -$17.4M | $8.9M | $13.4M | |
| Net Income to Company | -$11.4M | $13.2M | -$46.8M | $228.9M | $162.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.4M | $3.6M | -$23.4M | $114.5M | $125.8M | |
| Basic EPS (Cont. Ops) | -$0.08 | $0.03 | -$0.19 | $0.95 | $1.15 | |
| Diluted EPS (Cont. Ops) | -$0.08 | $0.03 | -$0.19 | $0.94 | $1.14 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $345.9M | $372.5M | $397.1M | $399.4M | $442.1M | |
| EBIT | $40.7M | $68.6M | $91.6M | $195M | $233.1M | |
| Revenue (Reported) | $605.1M | $683.1M | $789.8M | $812.4M | $871.7M | |
| Operating Income (Reported) | $40.7M | $68.6M | $91.6M | $195M | $233.1M | |
| Operating Income (Adjusted) | $40.7M | $68.6M | $91.6M | $195M | $233.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $458.6M | $527.2M | $596M | $617.7M | $658.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $342.3M | $371.9M | $399.2M | $322M | $347.5M | |
| Gross Profit | $116.3M | $155.3M | $196.8M | $295.7M | $311.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.2M | $10.5M | $14.5M | $19.9M | $14.6M | |
| Selling, General & Admin | -- | -- | -- | $44M | $115.9M | |
| Other Inc / (Exp) | -$1.1M | -$374K | $981K | -$291K | -$2.6M | |
| Operating Expenses | $80.7M | $97.4M | $123.9M | $147M | $130.5M | |
| Operating Income | $35.6M | $57.9M | $72.8M | $148.7M | $180.7M | |
| Net Interest Expenses | $61.1M | $51.1M | $80.6M | $77.1M | $74M | |
| EBT. Incl. Unusual Items | -$23.5M | $10.5M | -$35M | $79.3M | $111.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$20M | $1M | -$16.7M | $18.5M | $19.6M | |
| Net Income to Company | -$3.4M | $19.1M | -$45.2M | $152.9M | $89.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.4M | $9.5M | -$22.6M | $76.4M | $89.5M | |
| Basic EPS (Cont. Ops) | -$0.03 | $0.07 | -$0.18 | $0.64 | $0.83 | |
| Diluted EPS (Cont. Ops) | -$0.03 | $0.07 | -$0.18 | $0.63 | $0.83 | |
| Weighted Average Basic Share | $401.3M | $386.3M | $378.5M | $361.2M | $323.7M | |
| Weighted Average Diluted Share | $402.9M | $390.5M | $380.2M | $363.3M | $325.3M | |
| EBITDA | $264.9M | $285.6M | $302.5M | $300.3M | $338.2M | |
| EBIT | $35.6M | $57.9M | $72.8M | $148.7M | $180.7M | |
| Revenue (Reported) | $458.6M | $527.2M | $596M | $617.7M | $658.7M | |
| Operating Income (Reported) | $35.6M | $57.9M | $72.8M | $148.7M | $180.7M | |
| Operating Income (Adjusted) | $35.6M | $57.9M | $72.8M | $148.7M | $180.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $244.7M | $320.9M | $168.8M | $71.9M | $93.5M | |
| Short Term Investments | $7.5M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $61.2M | $63.4M | $82.3M | $91.7M | $98.8M | |
| Inventory | $32.5M | $29M | $39.8M | $91.1M | $81.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $9.5M | $11M | $15.4M | $16.4M | $19.1M | |
| Total Current Assets | $344M | $424.4M | $306.2M | $271.1M | $292.7M | |
| Property Plant And Equipment | $2.9B | $2.7B | $2.5B | $2.2B | $2.1B | |
| Long-Term Investments | -- | $4.9M | $142.2M | $133.6M | $89.8M | |
| Goodwill | -- | -- | -- | -- | $98.2M | |
| Other Intangibles | $45.5M | $44M | $42.6M | $41.1M | $90.9M | |
| Other Long-Term Assets | $50.5M | $50.1M | $122.1M | $86.7M | $66.6M | |
| Total Assets | $3.4B | $3.2B | $3B | $2.7B | $2.7B | |
| Accounts Payable | $14.4M | $16.2M | $21.4M | $28.7M | $19.7M | |
| Accrued Expenses | $49.5M | $48.1M | $68M | $54.8M | $64.8M | |
| Current Portion Of Long-Term Debt | $16.8M | $16.5M | $16.5M | $15M | $33.1M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $113.1M | $108.8M | $141.6M | $131.6M | $169.2M | |
| Long-Term Debt | $1.6B | $1.6B | $1.5B | $1.5B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $1.9B | $1.8B | $1.8B | $2.1B | |
| Common Stock | $134K | $131K | $126K | $123K | $110K | |
| Other Common Equity Adj | -$17.2M | -$7.1M | $51.6M | $33.9M | $18.3M | |
| Common Equity | $1.4B | $1.3B | $1.1B | $888.1M | $576.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.4B | $1.3B | $1.1B | $888.1M | $576.6M | |
| Total Liabilities and Equity | $3.4B | $3.2B | $3B | $2.7B | $2.7B | |
| Cash and Short Terms | $244.7M | $320.9M | $168.8M | $71.9M | $93.5M | |
| Total Debt | $1.6B | $1.6B | $1.5B | $1.5B | $1.8B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $289M | $218.8M | $67.9M | $159.6M | $88.5M | |
| Short Term Investments | $2M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $70.4M | $86.8M | $100.7M | $96.5M | $94.5M | |
| Inventory | $23.4M | $39.2M | $71.1M | $82.2M | $76.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $9.8M | $13.4M | $13.2M | $16.6M | -- | |
| Total Current Assets | $392.6M | $358.2M | $252.9M | $354.9M | $276M | |
| Property Plant And Equipment | $2.7B | $2.5B | $2.2B | $2.1B | $2B | |
| Long-Term Investments | $2.3M | $176.4M | $162.2M | $84.7M | $63.5M | |
| Goodwill | -- | -- | -- | $100.3M | -- | |
| Other Intangibles | -- | -- | -- | $93.2M | -- | |
| Other Long-Term Assets | $48.8M | $181.2M | $113.3M | $60.2M | -- | |
| Total Assets | $3.2B | $3.1B | $2.7B | $2.8B | $2.6B | |
| Accounts Payable | $10.9M | $28.4M | $14.4M | $13.6M | $13.2M | |
| Accrued Expenses | $39.8M | $46.1M | $59.2M | $55.8M | -- | |
| Current Portion Of Long-Term Debt | -- | $16.5M | $11.3M | $18.3M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $93.5M | $126.8M | $119M | $135.3M | $103.2M | |
| Long-Term Debt | $1.6B | $1.6B | $1.5B | $1.8B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9B | $1.9B | $1.8B | $2.1B | $2.1B | |
| Common Stock | $132K | $126K | $124K | $114K | $105K | |
| Other Common Equity Adj | -$10.2M | $57M | $53.2M | $15.4M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.3B | $1.1B | $925M | $663.8M | $450.5M | |
| Total Liabilities and Equity | $3.2B | $3.1B | $2.7B | $2.8B | $2.6B | |
| Cash and Short Terms | $289M | $218.8M | $67.9M | $159.6M | $88.5M | |
| Total Debt | $1.6B | $1.6B | $1.5B | $1.8B | $1.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$56.1M | -$9.3M | $17.4M | $30.8M | $225.6M | |
| Depreciation & Amoritzation | $303.2M | $305.4M | $303.5M | $282.5M | $203.1M | |
| Stock-Based Compensation | $16.7M | $26.8M | $43.7M | $57.5M | $63.5M | |
| Change in Accounts Receivable | $6.4M | -$1.8M | -$18.7M | -$9.5M | -$6.4M | |
| Change in Inventories | $7.2M | $3.6M | -$10.2M | -$51M | $9.8M | |
| Cash From Operations | $249.8M | $302.9M | $344.7M | $314.9M | $376M | |
| Capital Expenditures | $38.7M | $42.1M | $71.3M | $73.5M | $69.9M | |
| Cash Acquisitions | -- | -- | -- | -- | $110.7M | |
| Cash From Investing | -$46.5M | -$36.4M | -$121.3M | -$83.5M | -$180.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $64.8M | $64.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $202M | $179.3M | -- | $63.9M | $419.8M | |
| Long-Term Debt Repaid | -$395.8M | -$195.8M | -$116.5M | -$72.3M | -$114.2M | |
| Repurchase of Common Stock | -- | $163.4M | $257.1M | $247M | $407.7M | |
| Other Financing Activities | -$7.1M | -$10M | -$5.3M | -$10.8M | -$7M | |
| Cash From Financing | -$188.2M | -$182.5M | -$375M | -$327.1M | -$170.5M | |
| Beginning Cash (CF) | $237.2M | $320.9M | $168.8M | $71.9M | $93.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.6M | $83.7M | -$152.1M | -$96.9M | $21.7M | |
| Ending Cash (CF) | $249.3M | $404.4M | $16M | -$26.3M | $112M | |
| Levered Free Cash Flow | $211.1M | $260.7M | $273.5M | $241.4M | $306.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$735K | $4.3M | -$24.3M | $48.9M | -$67.6M | |
| Depreciation & Amoritzation | $77.7M | $76.4M | $76.8M | $51.2M | $53M | |
| Stock-Based Compensation | $7.5M | $13.7M | $15.9M | $17.7M | $13.2M | |
| Change in Accounts Receivable | -$6.6M | -$11.9M | -$8.8M | -$420K | -$13.4M | |
| Change in Inventories | $5.1M | -$11.2M | -$15.3M | $3.4M | $1.3M | |
| Cash From Operations | $87.2M | $88.9M | $71.1M | $118.6M | $100.8M | |
| Capital Expenditures | $8.8M | $13.7M | $12M | $18.6M | $21.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.8M | -$13.7M | -$12M | -$18.6M | -$21.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $16.1M | $16.3M | $16.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $179.3M | -- | $63.9M | $198M | -- | |
| Long-Term Debt Repaid | -$182.8M | -$4.1M | -$64.1M | -$54.6M | -- | |
| Repurchase of Common Stock | $2.6M | $80.2M | $75.4M | $129.8M | $50.4M | |
| Other Financing Activities | -$4.7M | -$574K | -$1.9M | -$874K | -- | |
| Cash From Financing | -$8.5M | -$83M | -$93.4M | -$3.3M | -$69.8M | |
| Beginning Cash (CF) | $287M | $218.8M | $67.9M | $159.6M | $88.5M | |
| Foreign Exchange Rate Adjustment | -$258K | -$565K | -$1.3M | -$653K | -$203K | |
| Additions / Reductions | $73.6M | -$8.4M | -$35.6M | $96M | $9.2M | |
| Ending Cash (CF) | $360.3M | $209.8M | $31M | $255M | $97.6M | |
| Levered Free Cash Flow | $78.4M | $75.2M | $59.1M | $100M | $79.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.4M | $13.2M | -$46.8M | $228.9M | $162.2M | |
| Depreciation & Amoritzation | $305.2M | $303.9M | $343M | $167M | $208.9M | |
| Stock-Based Compensation | $24.2M | $38.3M | $57.6M | $63M | $56.4M | |
| Change in Accounts Receivable | -$10.3M | -$16.2M | -$14.3M | $5.4M | $2.2M | |
| Change in Inventories | $9.9M | -$15.5M | -$31.5M | -$11.2M | $6.4M | |
| Cash From Operations | $283.8M | $344.2M | $317.4M | $359M | $396.3M | |
| Capital Expenditures | $37.4M | $58.9M | $83.8M | $61.8M | $91.1M | |
| Cash Acquisitions | -- | -- | -- | $110.7M | -- | |
| Cash From Investing | -$40.9M | -$107.4M | -$93.8M | -$172.5M | -$91.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $48.8M | $65.1M | $62.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $63.9M | $469.8M | -- | |
| Long-Term Debt Repaid | -$195.8M | -$16.5M | -$176.4M | -$159.6M | -- | |
| Repurchase of Common Stock | $125.1M | $287.7M | $202.8M | $336.5M | $309.6M | |
| Other Financing Activities | -$10M | -$5.1M | -$10.5M | -$6.5M | -- | |
| Cash From Financing | -$139.4M | -$306.5M | -$369.6M | -$94.8M | -$376.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $104.3M | -$68.2M | -$150.9M | $91.7M | -$71.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $246.3M | $285.3M | $233.6M | $297.1M | $305.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.4M | $19.1M | -$45.2M | $152.9M | $89.5M | |
| Depreciation & Amoritzation | $229.3M | $227.7M | $267.2M | $151.7M | $157.5M | |
| Stock-Based Compensation | $20.1M | $31.6M | $45.5M | $51M | $44M | |
| Change in Accounts Receivable | -$8.7M | -$23.1M | -$18.7M | -$3.7M | $4.8M | |
| Change in Inventories | $9.4M | -$9.6M | -$31M | $8.8M | $5.3M | |
| Cash From Operations | $213.1M | $254.5M | $227.1M | $271.2M | $291.5M | |
| Capital Expenditures | $28M | $44.8M | $57.3M | $45.6M | $66.8M | |
| Cash Acquisitions | -- | -- | -- | $110.7M | -- | |
| Cash From Investing | -$23.7M | -$94.8M | -$67.3M | -$156.3M | -$66.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | $48.8M | $49.1M | $46.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $179.3M | -- | $63.9M | $469.8M | $50M | |
| Long-Term Debt Repaid | -$191.7M | -$12.4M | -$72.3M | -$159.6M | -$33M | |
| Repurchase of Common Stock | $125.1M | $249.4M | $195.1M | $284.6M | $186.5M | |
| Other Financing Activities | -$9.4M | -$4.6M | -$9.8M | -$5.5M | -$13.6M | |
| Cash From Financing | -$139.7M | -$263.8M | -$258.4M | -$26.2M | -$232.4M | |
| Beginning Cash (CF) | $715.2M | $678M | $297.9M | $397.2M | $218.7M | |
| Foreign Exchange Rate Adjustment | $164K | $1.9M | -$2.3M | -$958K | $2.7M | |
| Additions / Reductions | $49.8M | -$102.2M | -$100.9M | $87.7M | -$5M | |
| Ending Cash (CF) | $765.2M | $577.8M | $194.7M | $483.9M | $216.5M | |
| Levered Free Cash Flow | $185.1M | $209.7M | $169.8M | $225.5M | $224.7M | |
Related Companies
Get IRDM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IRDM
Sector
P/E ratio
16.66x
16.71x
PEG ratio
0.78x
0.00x
P/B ratio
4.43x
1.30x
Price / LTM sales
2.40x
0.85x
Growth Metrics
IRDM
Sector
Revenue growth
6.66%
1.07%
Earnings growth
68.45%
9.09%
Revenue (5-year growth)
8.19%
1.1%
Earnings forecast
$0.29
$0.07
Profitability
IRDM
Sector
Profitability FY 2024
$397M
$106.1M
Return on invested capital
5.37%
0.43%
Return on assets
4.78%
-0.17%
Return on equity
23.45%
1.42%
Earnings Date
Last Earnings Date
Oct
23
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Jan
22
Balance Sheet
IRDM
Sector
Total cash
$88.5M
$68.9M
Short term investments
--
$24.7M
Total assets
$2.7B
$546.7M
Long term debt
$1.8B
$10.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
